Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10478485
Methods and compositions to prevent or treat bacterial infections
granted -
US 10478404
Materials, methods and devices for altering cell reactivity
granted -
US 10479825
Antibody-mediated neutralization of Marburg virus
granted -
US 10472340
Substituted phenothiazines as mitochondrial agents
granted -
US 10471109
Compositions and methods for promoting nitric oxide production through an oral delivery system
granted -
US 10472330
Substituted triazenes protected from degradation by carboxylation of N1
granted -
US 10464994
Recombinant clusterin and use thereof in the treatment and prevention of disease
granted -
US 10463684
Nucleobase analogue derivatives and their applications
granted -
US 10463685
Telomerase mediated telomere altering compounds
granted -
US 10464983
Variants of adrenomedullin and calcitonin gene-related peptide and methods of use
granted -
US 10465227
Microbial testing devices, methods of making microbial testing devices and methods of identifying novel antimicrobial drug candidates
granted -
US 10457676
Capsazepine analogs for the treatment of cancer and other proliferative diseases
granted -
US 10457662
Substituted amides for treating and preventing cancer
granted -
US 10450352
Engineered polypeptides for antigen delivery
granted -
US 10448637
Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same
granted -
US 10450275
Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain
granted -
US 10449254
Ionic liquids for transdermal drug delivery
granted -
US 10451610
Prediction of response to PARP inhibitors and combinational therapy targeting C-MET and PARP1
granted -
US 10442911
Dendritic macroporous hydrogels prepared by crystal templating
granted -
US 10441607
Multifunctional linker technology containing an N4 group
granted -
US 10442182
In vivo live 3D printing of regenerative bone healing scaffolds for rapid fracture healing
granted -
US 10442852
Methods and compositions for treatment of symptoms associated with intracranial hemorrhage
granted -
US 10441586
CRMP2 SUMOylation inhibitors and uses thereof
granted -
US 10434075
FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer
granted